These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 18402560)

  • 21. U-shaped relationship of blood glucose with adverse outcomes among patients with ST-segment elevation myocardial infarction.
    Pinto DS; Skolnick AH; Kirtane AJ; Murphy SA; Barron HV; Giugliano RP; Cannon CP; Braunwald E; Gibson CM;
    J Am Coll Cardiol; 2005 Jul; 46(1):178-80. PubMed ID: 15992655
    [No Abstract]   [Full Text] [Related]  

  • 22. Metabolic management of acute myocardial infarction comes to the fore and extends beyond control of hyperglycemia.
    Opie LH
    Circulation; 2008 Apr; 117(17):2172-7. PubMed ID: 18443246
    [No Abstract]   [Full Text] [Related]  

  • 23. Blood glucose and its prognostic implications in patients hospitalised with acute myocardial infarction.
    Kosiborod M
    Diab Vasc Dis Res; 2008 Nov; 5(4):269-75. PubMed ID: 18958836
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Glucose control in the intensive care unit.
    Fahy BG; Sheehy AM; Coursin DB
    Crit Care Med; 2009 May; 37(5):1769-76. PubMed ID: 19325461
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Perioperative glycemic control: an evidence-based review.
    Lipshutz AK; Gropper MA
    Anesthesiology; 2009 Feb; 110(2):408-21. PubMed ID: 19194167
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hyperglycaemia in acute coronary syndromes: risk-marker or therapeutic target?
    Anantharaman R; Heatley M; Weston CF
    Heart; 2009 May; 95(9):697-703. PubMed ID: 18697807
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Targeting glucose in acute myocardial infarction: has glucose, insulin, and potassium infusion missed the target?
    Chaudhuri A; Miller M; Nesto R; Rosenberg N; Dandona P
    Diabetes Care; 2007 Dec; 30(12):3026-8. PubMed ID: 17848612
    [No Abstract]   [Full Text] [Related]  

  • 28. Blood glucose control in 2010: 110 to 150 mg/dL and minimal variability.
    Vincent JL
    Crit Care Med; 2010 Mar; 38(3):993-5. PubMed ID: 20168161
    [No Abstract]   [Full Text] [Related]  

  • 29. Association of elevated fasting glucose with increased short-term and 6-month mortality in ST-segment elevation and non-ST-segment elevation acute coronary syndromes: the Global Registry of Acute Coronary Events.
    Sinnaeve PR; Steg PG; Fox KA; Van de Werf F; Montalescot G; Granger CB; Knobel E; Anderson FA; Dabbous OH; Avezum A;
    Arch Intern Med; 2009 Feb; 169(4):402-9. PubMed ID: 19237725
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Glucose level and brain infarction: a prospective case-control study and prospective study.
    Mazighi M; Labreuche J; Amarenco P
    Int J Stroke; 2009 Oct; 4(5):346-51. PubMed ID: 19765122
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Lowering glucose to prevent adverse cardiovascular outcomes in a critical care setting.
    Ceriello A; Zarich SW; Testa R
    J Am Coll Cardiol; 2009 Feb; 53(5 Suppl):S9-13. PubMed ID: 19179217
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Impact of admission blood glucose on outcomes of nondiabetic patients with acute ST-elevation myocardial infarction (from the German Acute Coronary Syndromes [ACOS] Registry).
    Naber CK; Mehta RH; Jünger C; Zeymer U; Wienbergen H; Sabin GV; Erbel R; Senges J; Gitt A
    Am J Cardiol; 2009 Mar; 103(5):583-7. PubMed ID: 19231316
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Primary percutaneous coronary intervention in comatose survivors of cardiac arrest with ST-elevation acute myocardial infarction: a single-center experience in Florence.
    Valente S; Lazzeri C; Saletti E; Chiostri M; Gensini GF
    J Cardiovasc Med (Hagerstown); 2008 Nov; 9(11):1083-7. PubMed ID: 18852577
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical benefit of early reperfusion therapy in patients with ST-elevation myocardial infarction usually excluded from randomized clinical trials (results from the Maximal Individual Therapy in Acute Myocardial Infarction Plus [MITRA Plus] registry).
    Koeth O; Zahn R; Gitt AK; Bauer T; Juenger C; Senges J; Zeymer U;
    Am J Cardiol; 2009 Oct; 104(8):1074-7. PubMed ID: 19801027
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Combined impact of age and estimated glomerular filtration rate on in-hospital mortality after percutaneous coronary intervention for acute myocardial infarction (from the American College of Cardiology National Cardiovascular Data Registry).
    Cardarelli F; Bellasi A; Ou FS; Shaw LJ; Veledar E; Roe MT; Morris DC; Peterson ED; Klein LW; Raggi P
    Am J Cardiol; 2009 Mar; 103(6):766-71. PubMed ID: 19268729
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Acute myocardial infarction, hyperglycemia, and insulin.
    Dandona P; Chaudhuri A; Ghanim H
    J Am Coll Cardiol; 2009 Apr; 53(16):1437-9. PubMed ID: 19371827
    [No Abstract]   [Full Text] [Related]  

  • 37. Modalities of treatment and 30-day outcomes of unselected patients older than 75 years with acute ST-elevation myocardial infarction: data from the BLITZ study.
    De Luca L; Bolognese L; Casella G; Savonitto S; Gonzini L; Di Chiara A; De Servi S; Notaristefano S; Valagussa L; Maggioni AP; Chiarella F;
    J Cardiovasc Med (Hagerstown); 2008 Oct; 9(10):1045-51. PubMed ID: 18799968
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prognostic role of glucose abnormalities in patients with ST-elevation myocardial infarction and mild renal impairment.
    Lazzeri C; Valente S; Chiostri M; Nesti M; D'Alfonso MG; Gensini GF
    Int J Cardiol; 2014 Feb; 171(2):e26-7. PubMed ID: 24342411
    [No Abstract]   [Full Text] [Related]  

  • 39. Alterations in glucose homeostasis in the pediatric intensive care unit: Hyperglycemia and glucose variability are associated with increased mortality and morbidity.
    Hirshberg E; Larsen G; Van Duker H
    Pediatr Crit Care Med; 2008 Jul; 9(4):361-6. PubMed ID: 18496414
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Defining the role of incretin mimetic therapy in the management of type 2 diabetes.
    Unger J; Nadeau DA
    J Fam Pract; 2007 Dec; 56(12 Suppl New):S4-S10. PubMed ID: 18664341
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.